Results 201 to 210 of about 22,889 (244)
Some of the next articles are maybe not open access.
Activity of topotecan in retinoblastoma
Ophthalmic Genetics, 2004To report our experience with topotecan in children with relapsed/refractory metastatic and intraocular retinoblastoma.Topotecan was administered intravenously as a 30-min infusion at a dose of 2 mg/m2/d for five consecutive days and repeated after three weeks.
Guillermo L, Chantada +5 more
openaire +2 more sources
Topotecan (Hycamptin) and Topotecan‐Containing Regimens in the Treatment of Hematologic Malignancies
Annals of the New York Academy of Sciences, 2000Abstract: Single‐agent topotecan is an active drug in chemotherapy‐naive MDS and CMML and, to a lesser degree, in refractory/relapsed acute leukemias, low‐/intermediate‐grade lymphoma, and myeloma. Its combination with cytosine arabinoside induces complete remissions in high‐risk MDS/CMML.
M, Beran, H M, Kantarjian
openaire +2 more sources